Organization
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
11 clinical trials
Clinical trial
Postmarketing Safety Study of Hemoporfin in Patients With Port Wine StainStatus: Completed, Estimated PCD: 2023-04-19
Clinical trial
A Pilot Study of Hemoporfin Photodynamic Therapy in Children (2-7 Years Old) With Port-wine StainStatus: Completed, Estimated PCD: 2023-02-15
Clinical trial
A Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, Sequential Group Comparison Study to Evaluate the Safety and Efficacy of Light Dose (Fluence) in Subjects With Port-wine Birthmark of the Face and/or Neck Treated With Hemoporfin + Green Light Photodynamic TherapyStatus: Not yet recruiting, Estimated PCD: 2026-01-01
Clinical trial
A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of F0002-ADC in Chinese Patients With Refractory or Recurrent CD30+ Hematologic Malignancies.Status: , Estimated PCD: 2022-12-01
Clinical trial
A PhaseⅠStudy to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of FDA018-ADC in Patients With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2029-12-01
Clinical trial
A PhaseⅠStudy to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of FDA022-BB05 in Subjects With Advanced Solid Malignant TumorsStatus: Not yet recruiting, Estimated PCD: 2024-03-01
Clinical trial
A PhaseⅠStudy to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of FZ-AD004 in Patients With Advanced Solid TumorsStatus: Not yet recruiting, Estimated PCD: 2025-12-01
Clinical trial
A Phase III Clinical Trial of Photodynamic Diagnosis for Malignant Brain Glioma With 5-Aminolevulinic AcidStatus: Not yet recruiting, Estimated PCD: 2025-08-01
Clinical trial
A Phase 2, Multicenter, Open-Label Study to Assess the Efficacy, Safety, Tolerability and Pharmacokinetics of FDA022-BB05 in Patients With Advanced/Metastatic Solid TumorsStatus: Not yet recruiting, Estimated PCD: 2025-07-31
Clinical trial
A Multi-center, Randomized, Double-blind, Placebo-controlled Phase IIc Clinical Trial of ALA-PDT in Patients With Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in p16-positivity and High-risk HPV InfectionStatus: Completed, Estimated PCD: 2023-12-20
Clinical trial
A PhaseⅠStudy to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of FZ-AD005 in Patients With Advanced Solid TumorsStatus: Not yet recruiting, Estimated PCD: 2025-12-01